UNKNOWN

ADAPTED_NOW

Tulane University School of Medicine is recruiting a Hematology and Oncology faculty member with a subspecialty focus in Leukemia or Bone Marrow Transplant to join a program where research leadership is built into the role, not tacked on. Trial 1: Phase III study in relapsed or refractory AML patients who have failed two to four prior induction therapies, with a 1:1 enrollment ratio between two treatment arms .

Leukemia & Bone Marrow Hematology/Oncology Faculty New Orleans, LouisianaMinimum 50% Protected Academic Time Tulane University School of Medicine is recruiting a Hematology and Oncology faculty member with a subspecialty focus in Leukemia or Bone Marrow Transplant to join a program where research leadership is built into the role, not tacked on. With at least 50% protected time, an active clinical trials portfolio, and a New Orleans address, this is an academic appointment worth a serious look. Practice Details <ul><li> Academic Hematology and Oncology faculty role with a focus on Leukemia or Bone Marrow Transplant </li><li> At least 50% protected time dedicated to research and academic pursuits </li><li> APP support for clinic and inpatient rounding </li><li> Active teaching role with fellows, residents, and medical students </li></ul>Clinical and Research Trials <ul><li>Trial 1: Phase III study in relapsed or refractory AML patients who have failed two to four prior induction therapies, with a 1:1 enrollment ratio between two treatment arms </li><li>Trial 2: Comparison of LOXO-305 versus idelalisib plus rituximab or bendamustine plus rituximab in previously treated CLL or SLL patients with prior BTK inhibitor exposure </li><li>Trial 3: Evaluation of blinatumomab in CD19-positive mixed phenotypic acute leukemia in patients with relapsed, refractory, or MRD-positive disease </li><li>Trial 4: Two-part dose confirmation and dose-finding study of venetoclax combined with AZA and CC-486 to establish the recommended Phase 3 dosing for each combination </li><li>Trial 5: Assessment of galinpepimut-S versus best available therapy in AML patients in second or subsequent complete remission </li></ul>Candidate Requirements <ul><li> Board Certified or Board Eligible in Hematology and Oncology </li><li> Subspecialty focus or experience in Leukemia or Bone Marrow Transplant </li><li> Strong interest in clinical trial leadership, academic publishing, and translational research </li><li> Commitment to teaching and mentoring in a multidisciplinary academic environment </li></ul>About Tulane University and New Orleans Tulane University School of Medicine has a growing research infrastructure and a strong regional footprint, anchored in one of the most culturally rich cities in the country. New Orleans offers world-renowned dining, a thriving arts scene, professional sports, and a historic character unlike any other in the United States. An international airport provides straightforward travel access, and the cost of living is reasonable relative to comparable academic markets. For a physician-researcher who wants a serious platform in a city that makes life outside the lab worth living, New Orleans delivers on both counts. A research-forward academic role with protected time, active trials, and New Orleans out the front door. Apply today.

Academic Researcher Jobs in Louisiana

Curative

Similar Job Searches